Skip to primary navigation Skip to main content
0 item $0.00

Dr Arpeeta Sharma

BSc(Hons), King’s College London | MSc and PhD, University of British Columbia, Vancouver, Canada

Dr Arpeeta Sharma is a Group Leader in the Cardiovascular Inflammation and Redox Biology laboratory at the Baker Heart and Diabetes Institute. She holds a BSc Hons (King’s College, London) and a Masters and PhD in Pharmacology from University of British Columbia, Vancouver, Canada (2014).

Dr Sharma has a proven track record in cardiovascular biology, in particular diabetes associated cardiovascular complications, endothelial dysfunction and atherosclerosis. She has published 26 papers in the field of vascular biology, including first author publications in high impact factor journals such as the Journal of Clinical Investigation, Diabetes and Atherosclerosis, Thrombosis and Vascular Biology.

In her PhD, Dr Sharma characterised a peptide that could up-regulate the release of protective nitric oxide, the first specific peptide of its kind, which is now undergoing chemical screening in Phase I clinical trials. In 2015, Dr Sharma was awarded the NHMRC Peter Doherty Early Career Fellowship to explore key antioxidant and anti-inflammatory pathways involved in diabetes-induced vascular disease as well as therapeutics to limit cellular damage, without triggering detrimental side effects. In addition,

Dr Sharma is the recipient of several project grants, including a Diabetes Australia Research Program General Grant (2019) and a Bayer Pharmaceuticals grant for New Indications (2019–2020). Dr Sharma has a growing international presence and is the inaugural recipient of the CSANZ-ACvA-ESC Ambassador Fellowship (Cardiovascular Society of Australia and New Zealand, Australian Cardiovascular Alliance, European Society of Cardiology).


  • CSANZ-ACvA-ESC Ambassador Fellowship (2020)
  • NHMRC Peter Doherty Early Career Fellowship (2015–2020)
  • Alexander Graham Bell Canada Graduate Scholarship (2010–2013)


  • Best Early Career Scientist oral presentation at Australian Atherosclerosis Society, AAS (2019)
  • Young Investigator Best Oral Presentation at AAS (2013)
  • K. Piafsky Trainee Presentation Award from the Canadian Society of Pharmacology and Therapeutics at the Experimental Biology Conference (2013)
  • Canada Governor General Award for Best Master’s Thesis (2011)
  • The Cornelis van Breeman Outstanding Young Investigator Award (2011)

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more